AF Carvalho, JR Machado, JL Cavalcante - Current Opinion in Psychiatry, 2009 - journals.lww.com Purpose of review: The majority of patients with depression fail to remit on one
or more antidepressant trials. These patients have treatment-resistant
depression (TRD) with high relapsing rates. Augmentation pharmacotherapy ... Cited by 2 - Related articles - All 3 versions
R Yoshimura, W Umene-Nakano, N Ueda, A … - Human Psychopharmacology: Clinical and …, 2008 - interscience.wiley.com In the present study, we examined the efficacy of risperidone addition on
sertraline-resistant depressed patients and the effects of risperidone on the
metabolism of sertraline. Ten patients (M/F: 4/6, age: 54 ± 10 years) met ... Cited by 2 - Related articles - All 3 versions
- ►furiousseasons.com [PDF] JC Nelson, GI Papakostas - American Journal of Psychiatry, 2009 - Am Psychiatric Assoc Objective: The authors sought to deter- mine by meta-analysis the efficacy and
tol- erability of adjunctive atypical antipsy- chotic agents in major depressive
disorder. Method: Searches were conducted of MEDLINE/PubMed (1966 to ... Cited by 1 - Related articles - All 4 versions
ME Thase, MH Trivedi, JC Nelson, M Fava, R … - Primary Care Companion to The Journal of Clinical …, 2008 - pubmedcentral.nih.gov A pooled analysis was performed on 2 identical 14-week studies (8-week
prospective antidepressant therapy treatment phase followed by 6-week randomized
double-blind phase) evaluating the efficacy of adjunctive aripiprazole ... Cited by 1 - Related articles - All 3 versions
PE Holtzheimer, CB Nemeroff - Current Psychiatry Reports, 2008 - Springer Most depressed patients fail to achieve remission despite adequate
antidepressant monotherapy, and a substantial minority show minimal improvement
despite optimal and aggressive therapy. However, major advances have taken ... Cited by 1 - Related articles - All 2 versions
A Dhir, SK Kulkarni - Neuroscience letters, 2008 - Elsevier Clinical studies have reported the beneficial outcome of addition of lower doses
of risperidone to antidepressant therapy specifically with selective serotonin
reuptake inhibitors (SSRIs) in the treatment of major depression. The ... Cited by 1 - Related articles - All 3 versions
AI Med - Ann Intern Med, 2007 - Am Coll Physicians Regarding internal validity, the authors did not describe the method of initial
diagnosis, or any measure of diagnostic reliability. Depressive disorder course,
number of prior episodes, or mood disorder subtype (eg, bipolar disorder or ...
GI Papakostas, RC Shelton - Current Psychiatry Reports, 2008 - Springer Despite the progressive increase in the number of pharmacologic agents with
potential antidepressant activity, many patients suffering from major depressive
disorder (MDD) continue to be symptomatic. Clearly, an urgent need exists ... Related articles - All 2 versions
TR Depression - Psychiatric Times, 2008 - psychiatrictimes.com A systematic review by Williams and Dale 41 of 24 randomized controlled trials
of either pharmacologic or psychotherapeutic interventions for cancer patients
with depression or depressive symptoms recently concluded that depression ... Related articles - Cached - All 3 versions
GI Papakostas - medscape.com Definitions of "adequate response" have varied throughout the course of the past
few decades, ranging from the more traditional view in which
treatment-resistance is defined as strict nonresponse, to the broadest ... Related articles - All 4 versions
